HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Animal alternative testing

This article was originally published in The Rose Sheet

Executive Summary

House bill introduced May 22 by Rep. Tom Lantos (D-Calif.) would permanently establish the Inter-Agency Coordinating Committee for the Validation of Alternative Methods (ICCVAM) as a standing committee from its current ad hoc status. The group would review and recommend in vitro testing methods to federal agencies as alternative methods to animal testing. The 29-member ICCVAM group has representation from a number of agencies, including FDA, the Environmental Protection Agency, the National Institutes of Health and the Consumer Product Safety Commission. Supporters of the bill include the Doris Day Animal League, Colgate-Palmolive, Gillette and Procter & Gamble...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel